Regadenoson

Rapiscan 400mcg solucion inyectable

400 µg solución inyectableSpainMarketedAuthorised 28 Jun 2013

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Regadenoson

Rapiscan 400mcg solucion inyectable

400 µg solución inyectableSpainMarketedAuthorised 28 Jun 2013

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pack	Code	Status
Rapiscan 400mcg solucion inyectable 5ml	698441

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Regadenoson
Strength: 400 µg
Dosage form: solución inyectable
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 28 Jun 2013
Registration: 110643001
Marketing authorisation holder: Ge Healthcare As
Procedure: EU centralised
Supply: Uso Hospitalario